Google Inc (GOOGL)’s New Wearable Is For The Medical Industry And Not Consumers

Share on FacebookTweet about this on TwitterShare on Google+Share on RedditShare on LinkedInPrint this pageEmail this to someone

Google Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) has developed a new wearable device that it is almost bringing out for testing this summer. However, the wearable would initially have a limited reach because the company has designed it with the medical industry in mind. Google’s new wearable doesn’t currently have a name, but it is promising to offer more accurate heath tracking.

Google’s research division called Google X has built what could be the most complex and accurate health tracking wearable. The new wearable is expected to enter testing in summer. Google has already tapped drugmakers and academics for testing of the device for its accuracy.

Not for consumer market

It is turning out that Google Inc (NASDAQ:GOOGL) would not bring the new wearable to the consumer market. According to Google’s head of life sciences, Andy Conrad, the intended use for the device is in the medical environment. Conrad said that the wearable could be something that physicians could prescribe to patients and also be used for clinical studies.

Google’s new wearable is capable of measuring heart rate, skin temperature. The devices can also measure external factors that include light and noise level in the surrounding of the wearer.

How the wearable could enter consumer market

Although the wearable is designed for medical use, it could still get in the hands of more consumers. According to Conrad, physicians could in future recommend the wearable to all their patients regardless of whether they are healthy or otherwise. If that happens, there is a great chance the device could end up almost in the status of a consumer device.

Wearables for medical use

In the clinical trial setting, drugmakers like Pfizer Inc. (NYSE:PFE) have cited that wearable devices are poor when it comes to clinical studies. Google’s more accurate wearable could help fix that problem to allow for more wearable use in clinical trials.

Neha Gupta

Neha Gupta has been in the financial space for over six years now. Gupta earned her MBA degree from Symbiosis Centre of Distance Learning in 2009 and her passion for finance led her to pursue Chartered Financial Analyst (CFA) course. She has successfully completed Level II of her CFA. She is a veteran in article writing, which is depicted in her numerous pieces published on SeekingAlpha, Nextiphonenews, InsiderMonkey, MarketWatch, and Techinsider. Her crisp and eloquent writing finds its best place in Researchcows, where emphasis is given on developing rich content for various websites, products, business plans, trainings, and book writing.

You may also like...

More in GOOGL
Google Inc (NASDAQ:GOOG)(NASDAQ:GOOGL)
Google Inc (GOOGL) Is On ‘Social Welfare Reduction’ Path As Per Prof Wu, Harvard And Yelp’s Study

A new study now accuses Google Inc (NASDAQ:GOOGL) of deliberately diluting the quality of its search results to punish rivals....

Close